Friday, Aug 19, 2022
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | India | Bharat Biotechs Covaxin 81 Pc Efficient In Phase 3 Clinical Trials

Bharat Biotech’s Covaxin 81 pc efficient in Phase 3 clinical trials

By PTI
Published: Updated On - 12:33 AM, Thu - 4 March 21
Bharat Biotech’s Covaxin 81 pc efficient in Phase 3 clinical trials
File Photo The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research, the Hyderabad-based company said in a statement.

New Delhi: Vaccine major Bharat Biotech on Wednesday said its COVID-19 vaccine, Covaxin, has demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials.

The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research, the Hyderabad-based company said in a statement.

“Today is an important milestone in vaccine discovery, for science and our fight against coronavirus. With today’s results from our Phase 3 clinical trials, we have now reported data on our COVID-19 vaccine from Phase 1, 2, and 3 trials involving around 27,000 participants,”

Bharat Biotech Chairman and Managing Director Krishna Ella said.

Covaxin demonstrates high clinical efficacy trend against COVID-19 but also significant immunogenicity against the rapidly emerging variants, he added.

Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Covaxin and Oxford-AstraZeneca’s Covishield are the two vaccines that are being administered in the country.

 


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

  • Follow Us :
  • Tags
  • Bharat Biotech
  • Covaxin
  • Indian Council of Medical Research
  • Phase 3 clinical trials

Related News

  • Bharat Biotech completes trials for India’s first intranasal Covid vaccine

    Bharat Biotech completes trials for India’s first intranasal Covid vaccine

  • CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

    CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

  • India reports 14,830 new Covid cases, 36 fatalities

    India reports 14,830 new Covid cases, 36 fatalities

  • ‘No cases of monkeypox reported in Telangana’

    ‘No cases of monkeypox reported in Telangana’

  • Children below 12 years at lower risk of contracting severe COVID infection: ICMR scientist

    Children below 12 years at lower risk of contracting severe COVID infection: ICMR scientist

  • ‘Covaxin safe, well-tolerated in paediatrics’

    ‘Covaxin safe, well-tolerated in paediatrics’

Latest News

  • AIMIM to contest Uttar Pradesh municipal polls

    4 mins ago
  • FIFA sells 2.45 million tickets for 2022 World Cup in Qatar

    19 mins ago
  • Twitter avoiding sharing information on bot accounts: Musk

    33 mins ago
  • Cricketer Yuzvendra Chahal clarifies divorce rumours with wife Dhanashree

    37 mins ago
  • Sekhar Kammula shares his exhilarating experience of watching ‘Gandhi’ in theatre with school children 

    37 mins ago
  • Consumer court slaps Rs 95k fine on Ola Cabs for poor service, overcharging

    37 mins ago
  • KTR hits back at trolls alleging inaction in Hyderabad rape case

    40 mins ago
  • Demolition drive triggers midnight tension in Andhra town

    48 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam